Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,736 | 20,779 | 23,694 | 19,398 | 15,086 |
| Marketable Securities | 86,236 | 107,217 | 57,539 | 66,097 | 80,509 |
| Receivables | 1,127 | 4,079 | 4,055 | 4,399 | 2,673 |
| TOTAL | $110,509 | $134,903 | $87,815 | $93,603 | $101,841 |
| Non-Current Assets | |||||
| PPE Net | 14,266 | 15,186 | 15,949 | 16,228 | 16,869 |
| Investments And Advances | 8,483 | 8,656 | 9,406 | 12,700 | 11,682 |
| Intangibles | 14,740 | 15,007 | 15,274 | 15,540 | 15,807 |
| Other Non-Current Assets | 17,075 | 17,414 | 2,670 | 2,626 | 2,724 |
| TOTAL | $54,564 | $56,263 | $43,298 | $47,094 | $47,082 |
| Total Assets | $165,073 | $191,166 | $131,113 | $140,696 | $148,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,042 | 16,960 | 24,113 | 18,016 | 13,211 |
| Accrued Expenses | 4,638 | 7,159 | 5,672 | 7,353 | 10,360 |
| Other current liabilities | N/A | N/A | N/A | N/A | 229 |
| TOTAL | $24,079 | $27,415 | $35,300 | $27,998 | $28,406 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,451 | 1,407 | 5,516 | 2,629 | 4,607 |
| Other Non-Current Liabilities | 84,484 | 82,687 | 87 | 100 | 0 |
| TOTAL | $84,516 | $82,784 | $8,781 | $8,989 | $9,025 |
| Total Liabilities | $108,595 | $110,199 | $44,081 | $36,987 | $37,431 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,249 | 8,166 | 8,133 | 7,942 | 7,622 |
| Common Shares | 99 | 98 | 97 | 95 | 92 |
| Retained earnings | -679,033 | -649,646 | -620,427 | -587,131 | -562,115 |
| Other shareholders' equity | 3,593 | 3,347 | -433 | -186 | -502 |
| TOTAL | $56,478 | $80,966 | $87,032 | $103,709 | $111,492 |
| Total Liabilities And Equity | $165,073 | $191,166 | $131,113 | $140,696 | $148,923 |